Navigation Links
The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
Date:1/25/2013

Brookline, MA (PRWEB) January 25, 2013

Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to the doctor’s office every few weeks to few months. A new surgically implanted device may for the first time allow home monitoring of eye pressure.Once inside the eye, it relays measurements to a remote-held reader wirelessly.

Following years of animal research, Samir Melki MD PhD of Harvard Medical School and the Boston Eye Group implanted the device for the first time in a patient with Glaucoma during cataract surgery. “This may be a game-changer when it comes to glaucoma management” said Dr. Melki. “ It should allow us to understand the disease through a tremendous ability to collect pressure data”

The wireless intraocular pressure transducerwas developed by Implandata GmbH (Hannover, Germany). It integrates pressure sensors, temperature sensor, identification encoder, analog-to-digital encoder, and telemetry unit into a single microelectromechanical system-application specific integrated circuit (MEMS-ASIC). This digital ultra-miniature system employs complementary metal oxide semiconductor (CMOS) technology for its electronic components. The electronic components are either biocompatible or inert. The ASIC is attached to a circular microcoil antenna made of gold and both of these components are hermetically encapsulated in platinum-cured silicone. This biocompatible silicone material makes up the entire surface of the implant. The implant itself is designed to remain in-vivo indefinitely. The outside diameter of the transponder disc is only 11.3 mm, inside diameter is 7 mm, its thickness is 0.9 mm and the weight is 0.1 g.

“The device seems to be very well tolerated in the eye” said Melki, who implanted the device 18months ago at the Beirut Eye Specialist Hospital. “Although more studies need to be conducted, we have seen no side effects until now”.

There are several benefits to the novelmethod.It allows IOP measurements wirelessly through radiofrequency whichoffers the prospect of lifelong frequent eye pressure monitoring. It may reduce the number of doctors’ visits and provide measurements at times that were inaccessible previously such as during sleep. This may allow glaucoma specialists to understand why certain patients still lose vision despite seemingly low pressures. The device is not FDA-approved at this time.

For more information, contact Rick Young at Rick(at)bostoneyegroup(dot)com or Max Ostermeier at mostermeier(at)implandata(dot)com. You can also visit http://www.bostoneyegroup.com or call 617-566-0062.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10354744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Linguists to gather in Boston for National Conference
2. Northofbostonusa.com Will Release its N5 Fashion Shoes Next Monday
3. Boston College researcher looks to stop a deadly parasite in its tracks
4. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
5. Cincinnati and Boston Childrens Hospitals receive an NIH Autism Center of Excellence Grant
6. Boston University researchers expand synthetic biologys toolkit
7. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
8. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
9. Boston researcher, surgical oncologist receives national award
10. Leaders in childrens health to gather in Boston
11. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: